Cargando…
CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function
Human CYP2B6 enzyme although constitutes relatively low proportion (1–4%) of hepatic cytochrome P450 content, it is the major catalyst of metabolism of several clinically important drugs (efavirenz, cyclophosphamide, bupropion, methadone). High interindividual variability in CYP2B6 function, contrib...
Autores principales: | Mangó, Katalin, Kiss, Ádám Ferenc, Fekete, Ferenc, Erdős, Réka, Monostory, Katalin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863776/ https://www.ncbi.nlm.nih.gov/pubmed/35194103 http://dx.doi.org/10.1038/s41598-022-07022-9 |
Ejemplares similares
-
Association between CYP2B6 genetic variability and cyclophosphamide therapy in pediatric patients with neuroblastoma
por: Mangó, Katalin, et al.
Publicado: (2023) -
CYP1A2 mRNA Expression Rather than Genetic Variants Indicate Hepatic CYP1A2 Activity
por: Fekete, Ferenc, et al.
Publicado: (2022) -
Impact of genetic and non-genetic factors on hepatic CYP2C9 expression and activity in Hungarian subjects
por: Fekete, Ferenc, et al.
Publicado: (2021) -
CYP1A2 expression rather than genotype is associated with olanzapine concentration in psychiatric patients
por: Fekete, Ferenc, et al.
Publicado: (2023) -
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
por: Menus, Ádám, et al.
Publicado: (2020)